Skip to content

HemocareLact on Prolactin Levels

Safety and Efficacy of HemocareLact Granules and HemocareLact Capsules on Breast Milk Production and Prolactin Levels in Postpartum Mothers

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019728
Enrollment
120
Registered
2019-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: HemocareLact Capsule: Galactogogues with Iron 1 Capsule BID for 3 months Control Intervention1: HemocareLact Granules: Galactogogues with Iron 1 spoonful (10g) after breakfast and after

Sponsors

MMC Pharmaceuticals Ltd
Lead Sponsor
SRM Institute of Science and Technology
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Mothers who willing to exclusively breastfeed their infants Mothers who willing to give informed consent

Exclusion criteria

Exclusion criteria: Mothers who delivered infants with low birth weight Mothers who delivered infants with any illnesses or congenital abnormalities Mothers with any breast problems such as inverted nipples, mastitis, engorgement, cracks etc., Mothers taking herbs or any breastfeeding supplements

Design outcomes

Primary

MeasureTime frame
Estimation of Prolactin Levels Estimation of Hemoglobin LevelsTimepoint: 0, 15th day, 30th day

Secondary

MeasureTime frame
ADRs during study periodTimepoint: 0, 15th day, 30th day

Countries

India

Contacts

Public ContactDr KS Lakshmi

SRM College of Pharmacy

shrilatha1996@gmail.com04427453160

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026